Breast cancer (BrCa) is a pressing health concern, necessitating the development of effective imaging and therapeutic agents. To address this need, we designed and synthesized molecularly targeted imaging and therapeutic agents that combine visualization and treatment of tumors in real-time. Our approach involved the development of dual-modal agents, incorporating the fluorescent near infrared (NIR) dye, IRDye78, and a chlorin-based photosensitizer (PS) dye,Mesopyropheoborbide-a (mPPa), coupled to a BrCa-targeting peptide, "18-4."Additionally, we created a water-soluble, single-modal targeted PS probe for
photodynamic therapy (PDT) of BrCa for use guided by other imaging methods
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
(nessuna copia disponibile)
Cerca: Inserisci un desiderataNon riesci a trovare il libro che stai cercando? Continueremo a cercarlo per te. Se uno dei nostri librai lo aggiunge ad AbeBooks, ti invieremo una notifica!
Inserisci un desiderata